Naoki Yamamoto
#179,648
Most Influential Person Now
Naoki Yamamoto's AcademicInfluence.com Rankings
Naoki Yamamotochemistry Degrees
Chemistry
#5479
World Rank
#6668
Historical Rank
Organic Chemistry
#967
World Rank
#1091
Historical Rank
Naoki Yamamotobiology Degrees
Biology
#14978
World Rank
#18865
Historical Rank
Biochemistry
#2629
World Rank
#2805
Historical Rank
Download Badge
Chemistry Biology
Naoki Yamamoto's Degrees
- PhD Chemistry University of Tokyo
- Masters Chemistry University of Tokyo
- Bachelors Chemistry University of Tokyo
Why Is Naoki Yamamoto Influential?
(Suggest an Edit or Addition)Naoki Yamamoto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection (1997) (331)
- Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100 (1994) (298)
- A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. (1998) (283)
- T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer (2003) (271)
- Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. (1992) (232)
- Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. (1987) (205)
- Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). (1988) (196)
- Regioselective syntheses of sulfated polysaccharides: specific anti-HIV-1 activity of novel chitin sulfates. (1998) (191)
- Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus (1987) (186)
- Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae (1987) (182)
- Inhibition of human immunodeficiency viral replication by tannins and related compounds. (1992) (166)
- Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion (1992) (151)
- Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent (2004) (135)
- Defensins inhibit HIV replication in vitro. (1993) (129)
- Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro (1986) (119)
- Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. (2001) (119)
- Antiviral properties of a mangrove plant, Rhizophora apiculata Blume, against human immunodeficiency virus. (1999) (113)
- Structural requirement for the two-step dimerization of human immunodeficiency virus type 1 genome. (2000) (106)
- Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes. (2000) (105)
- A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance. (1993) (101)
- Synthesis and structural analysis of curdlan sulfate with a potent inhibitory effect in vitro of AIDS virus infection (1990) (96)
- Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists. (2003) (93)
- Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. (1995) (93)
- Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. (1991) (89)
- Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives. (1989) (85)
- Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro. (1994) (85)
- Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. (1992) (84)
- Sulfation of the immunomodulating polysaccharide lentinan: a novel strategy for antivirals to human immunodeficiency virus (HIV). (1988) (83)
- Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2. (1995) (81)
- Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro. (1989) (79)
- Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. (2005) (79)
- A survey of some Indian medicinal plants for anti-human immunodeficiency virus (HIV) activity. (2000) (78)
- In vitro anti human immunodeficiency virus activity of mangrove plants. (1996) (78)
- Anti-HIV activity of dextran sulphate as determined under different experimental conditions. (1989) (77)
- Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds. (2005) (76)
- Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro. (1987) (74)
- Inhibitory effect of new antibiotic, pradimincin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro. (1988) (69)
- In vitro anti-human immunodeficiency virus activity of polysaccharide from Rhizophora mucronata Poir. (1999) (67)
- Solution RNA structures of the HIV-1 dimerization initiation site in the kissing-loop and extended-duplex dimers. (2005) (59)
- Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives. (2003) (59)
- Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia (2004) (58)
- Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection. (1998) (58)
- HIV-1 reproduction is inhibited by peptides derived frm the N- and C-termini of HIV-1 protease. (1991) (57)
- HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain (2009) (56)
- Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection. (1992) (56)
- Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II). (1998) (55)
- Identification and cloning of a novel cellular protein Naf1, Nef‐associated factor 1, that increases cell surface CD4 expression 1 (1999) (51)
- Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity. (2001) (51)
- Synthesis of polymethacrylate derivatives having sulfated maltoheptaose side chains with anti‐HIV activities (1999) (49)
- Synthesis of sulfated oligosaccharide glycosides having high anti-HIV activity and the relationship between activity and chemical structure. (1999) (49)
- Synthesis, structure and antiviral activity of sulfates of cellulose and its branched derivatives (1990) (48)
- Identification of a new class of low molecular weight antagonists against the chemokine receptor CXCR4 having the dipicolylamine-zinc(II) complex structure. (2006) (48)
- Human immunodeficiency virus (HIV)-induced cell fusion: quantification and its application for the simple and rapid screening of anti-HIV substances in vitro. (1988) (48)
- Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica (2004) (48)
- Structure-activity relationships of an anti-HIV peptide, T22. (1994) (47)
- Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. (1990) (45)
- Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins. (1992) (43)
- Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products. (2013) (43)
- Specific biological activities of Chinese lacquer polysaccharides (2000) (41)
- Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening. (2008) (39)
- Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure. (1998) (37)
- Peptide HIV-1 integrase inhibitors from HIV-1 gene products. (2010) (37)
- Synthesis of sulfated alkyl malto- and laminara-oligosaccharides with potent inhibitory effects on AIDS virus infection. (1994) (37)
- Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 (1992) (36)
- A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification. (1987) (36)
- Synthesis of Sulfated Alkyl Laminara-Oligosaccharides Having Potent Anti-HIV Activity and the Relationship between Structure and Biological Activities (1994) (35)
- Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds. (2005) (35)
- Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. (2006) (32)
- 12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts. (1982) (32)
- Chemically sulfated natural galactomannans with specific antiviral and anticoagulant activities. (2016) (31)
- Fluorogenically active leucine zipper peptides as tag-probe pairs for protein imaging in living cells. (2009) (31)
- Interaction of an anti-HIV peptide, T22, with gp120 and CD4. (1996) (31)
- Antiviral agents with activity against human retroviruses. (1989) (30)
- Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo. (1987) (30)
- Roles of chemokines and chemokine receptors in HIV-1 infection. (2000) (30)
- A Synthetic C34 Trimer of HIV‐1 gp41 Shows Significant Increase in Inhibition Potency (2012) (29)
- Effects of Catuaba extracts on microbial and HIV infection. (1992) (28)
- Synthesis of sulfonated amino-polysaccharides having anti-HIV and blood anticoagulant activities. (1998) (28)
- Synthesis of an Inhibitor of Human Immunodeficiency Virus Infection (1989) (28)
- Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance. (1996) (27)
- Screening for inhibitors of avian myeloblastosis virus reverse transcriptase and effect on the replication of AIDS-virus. (1987) (26)
- [Chemokines and HIV-1 second receptors]. (1997) (26)
- Synthesis of Sulfated Alkyl Malto-oligosaccharides with Potent Inhibitory Effects on AIDS Virus Infection (1995) (26)
- Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus. (1992) (25)
- Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation. (2001) (25)
- NMR analysis of intra- and inter-molecular stems in the dimerization initiation site of the HIV-1 genome. (2000) (24)
- Anti-AIDS Virus Activity in vitro of Dextran Sulfates Obtained by Sulfation of Synthetic and Natural Dextrans (1993) (24)
- A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. (1987) (24)
- Azamacrocyclic Metal Complexes as CXCR4 Antagonists (2011) (24)
- Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus. (1991) (24)
- In vitro Activity of a Novel Series of Polyoxosilicotungstates against Human Myxo-, Herpes- and Retroviruses (1993) (23)
- An anti-HIV peptide, T22, forms a highly active complex with Zn(II). (1996) (23)
- Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro (1986) (23)
- Use of new phosphonylating and coupling agents in the synthesis of oligodeoxyribonucleotides via the H-phosphonate approach. (1990) (23)
- Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: The insertion of an (E)-alkene dipeptide isostere into the βII′-turn moiety (2002) (22)
- Role of the zinc fingers of HIV-1 nucleocapsid protein in maturation of genomic RNA. (2003) (22)
- LENTIVIRAL-MEDIATED DELIVERY OF COMBINED HIV-1 DECOY TAR AND Vif siRNA AS A SINGLE 1RNA MOLECULE THAT CLEAVES TO INHIBIT HIV-1 IN TRANSDUCED CELLS (2005) (22)
- Synthesis of sulfated derivatives of curdlan and their anti-HIV activity (1993) (22)
- Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression. (1999) (22)
- Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro (1988) (21)
- A Small Molecule CXCR 4 Inhibitor that Blocks T Cell Line – tropic HIV-1 Infection (1997) (21)
- Synthesis and in vitro inhibitory effect of L-glycosyl-branched curdlan sulfates on AIDS virus infection (1994) (21)
- Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan. (1987) (20)
- Multimerized CHR-derived peptides as HIV-1 fusion inhibitors. (2013) (20)
- Role of CXCR4 in HIV infection and its potential as a therapeutic target. (2010) (20)
- Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides (1993) (20)
- Efficient inhibition of SDF‐1α‐mediated chemotaxis and HIV‐1 infection by novel CXCR4 antagonists (2009) (20)
- Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. (1986) (20)
- Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virus. (1992) (19)
- Remodeling of dynamic structures of HIV-1 envelope proteins leads to synthetic antigen molecules inducing neutralizing antibodies. (2010) (19)
- Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore. (2008) (19)
- Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study. (2002) (18)
- Synthesis and anti-HIV activity of 3'-cyano-2',3'-dideoxythymidine and 3'-cyano-2',3'-didehydro-2',3'-dideoxythymidine (1988) (18)
- Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity. (1996) (18)
- Inhibition by doxorubicin of human immuno-deficiency virus (HIV) infection and replication in vitro. (1987) (18)
- Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies. (2010) (18)
- Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus (1995) (18)
- Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells. (1994) (18)
- Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells. (2004) (17)
- A strong inhibition of HIV-induced cytopathic effects by synthetic (1→6)-α-d-mannopyranan sulfate☆ (1991) (17)
- Inhibitory Effects of Polycations on the Replication of Enveloped Viruses (HIV, HSV, CMV, RSV, Influenza A Virus and Togaviruses) in vitro (1991) (17)
- Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins. (2012) (16)
- Synthesis of Cellulose-Type Polyriboses and Their Branched Sulfates with Anti-AIDS Virus Activity by Selective Ring-Opening Copolymerization of 1,4-Anhydro-.alpha.-D-ribopyranose Derivatives (1994) (16)
- Sulfated Alkyl Oligosaccharides Inhibit Human Immunodeficiency virus in vitro and Provide Sustained Drug Levels in Mammals (1995) (15)
- Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides. (2004) (15)
- Synthesis, structure and antiviral activity of sulfates of curdlan and its branched derivatives (1990) (15)
- Lignified materials as medicinal resources. VI. Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials. (1993) (15)
- Synthesis and anti-HIV activity of nonatyrosine N- and O1-9-decasulfate. (2001) (15)
- Synthesis of sulfated octadecyl ribo-oligosaccharides with potent anti-AIDS virus activity by ring-opening polymerization of a 1,4-anhydroribose derivative. (1996) (14)
- Anti-HIV activity of sulfonated arabinofuranan and xylofuranan (2001) (14)
- Synergistic inhibition of human immunodeficiency virus type 1 (HIV‐1) replication in vitro by sulphated paramylon and 3‘‐azido‐2’, 3‘‐dideoxythymidine (AZT) (1994) (14)
- Effect of pine seed shell extract on microbial and viral infection. (1992) (14)
- Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides. (1998) (14)
- Corrigendum to “conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity”: [Bioorg. Med. Chem. Lett. 11 (2001) 359] (2001) (14)
- Convenient one-pot synthesis of cystine-containing peptides using the trimethylsilyl chloride–dimethyl sulfoxide/trifluoroacetic acid system and its application to the synthesis of bifunctional anti-HIV compounds1 (1998) (13)
- Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice. (1996) (13)
- The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule. (1995) (12)
- Inhibition by sakyomicin A of avian myeloblastosis virus reverse transcriptase and proliferation of AIDS-associated virus (HTLV-III/LAV). (1986) (12)
- Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides. (2000) (12)
- Effects of DNA binding of the zinc finger and linkers for domain fusion on the catalytic activity of sequence-specific chimeric recombinases determined by a facile fluorescent system. (2012) (12)
- Plaque staining assay for non- or weakly cytotoxic human immunodeficiency virus (1987) (12)
- Anti-Human Immunodeficiency Virus (HIV) Activity of the Novel Antiviral Antibiotic Quartromicins which Enhance Inhibitory Effect of 3′-azido-2′,3′-dideoxythymidine (AZT) in vitro (1992) (12)
- Substances affecting the infection and replication of human immunodeficiency virus (HIV). (1986) (11)
- Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins. (2015) (11)
- Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands. (2019) (11)
- Increased HIV-1 sensitivity to neutralizing antibodies by mutations in the Env V3-coding region for resistance to CXCR4 antagonists. (2016) (11)
- Evaluation of a synthetic C34 trimer of HIV-1 gp41 as AIDS vaccines. (2012) (11)
- Pharmacophore-based small molecule CXCR4 ligands. (2012) (10)
- Effect of Degree of Sulfation on Anti-Hiv Activity of Synthetic (1→5)-α-D-Ribofuranan Sulfate (1991) (10)
- Anti-HIV activities and physicochemical properties of phosphorothioate analogues complementary to HIV sequences (1993) (10)
- Low-molecular-weight anti-HIV-1 peptides from the amino-terminal sequence of RANTES: possible lead compounds for coreceptor-directed anti-HIV-1 agents. (1999) (10)
- Conformational change of dimerization initiation site of HIV-1 genomic RNA by NCp7 or heat treatment. (2001) (10)
- Development of anti‐HIV peptides based on a viral capsid protein (2017) (10)
- Synthesis of some peptides corresponding to the active region of RANTES for chemotaxis and evaluation of their anti-human immunodeficiency virus-1 activity. (1997) (10)
- Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide. (1994) (8)
- Molecular Size of an Anti-HIV Peptide, T22, Can Be Reduced without Loss of the Activity (1996) (8)
- A Convenient Approach to the Synthesis of Azido-Acyclic Nucleosides (1989) (8)
- Susceptibility of diverse primary HIV isolates with varying co‐receptor specificity's to CXCR4 antagonistic compounds (2002) (8)
- In Vitro and in Vivo Transport and Delivery of Phosphorothioate Oligonucleotides with Cationic Liposomes (2004) (7)
- Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract. (1997) (7)
- Low‐Molecular‐Weight CXCR4 Ligands with Variable Spacers (2013) (7)
- Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV‐1 Fusion Inhibitors (2019) (7)
- Synthesis and chain length-anti-HIV activity relationship of fully N- and O-sulfated homooligomers of tyrosine. (2001) (7)
- Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study (2013) (7)
- Synthesis of Sulfated Deoxy-Ribofuranans Having Selective Anti-AIDS Virus Activity by Ring-Opening Copolymerization of 1,4-Anhydro Ribose Derivatives (1997) (6)
- Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment. (2020) (6)
- CXCR4-derived synthetic peptides inducing anti-HIV-1 antibodies. (2013) (5)
- Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells. (1999) (5)
- 5'-linked lipid-oligodeoxyridonucleotide derivatives as inhibitors of human immunodeficiency virus replication. (1996) (5)
- Sodium benzylideneascorbate induces apoptosis in HIV‐replicating U1 cells (1994) (5)
- Anti-HIV-1 peptides derived from partial amino acid sequences of CC-Chemokine RANTES (2002) (5)
- Inhibition of HIV replication by 19-O-n-pentyldamavaricin Fc in vitro. (1990) (4)
- Selective killing of human T cell lymphotropic virus type I-transformed cell lines by a damavaricin Fc derivative. (1989) (4)
- Anti‐HIV‐1 Peptide Derivatives Based on the HIV‐1 Co‐receptor CXCR4 (2013) (4)
- Properties and Anti-Hiv Activity of Hairpin Antisense Oligonucleotides Containing 2′-Methoxynucleosides with Base-Pairing in the Stem Region at the 3′-End (1996) (4)
- Properties and Anti-HIV Activity of Circular Sense and Antisense Oligonucleotides (1995) (4)
- A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro (1988) (3)
- The Middle to 3′ End of the Hiv-1 Vif Gene Sequence is Important for Vif Biological Activity and Could be Used for Antisense Oligonucleotide Targets (2005) (3)
- Efficacy of an Immunoglobulin Preparation from HIV Carriers in Preventing HIV Replication in vitro (1988) (3)
- Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells. (1988) (3)
- Phosphorothioate G3T4G3 motifs inhibits the early stage of HIV-1 infection. (1999) (3)
- Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment. (2020) (3)
- Properties and Anti-HIV Activity of Nicked Dumbbell Oligonucleotides (1996) (3)
- A strong inhibition of HIV-induced cytopathic effects by synthetic (1----6)-alpha-D-mannopyranan sulfate. (1991) (2)
- Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: the insertion of an (E)-alkene dipeptide isostere into the betaII'-turn moiety. (2002) (2)
- Antibody masking renders HIV-1 resistant to cationic membrane filtration through alteration of its electrostatic characteristics. (2001) (2)
- Anti-HIV-1 peptides derived from partial amino acid sequences of CC-chemokine RANTES. Regulated upon activation, normal T-cell expressed and secreted. (2002) (2)
- Double oral administration of emtricitabine/tenofovir prior to virus exposure protects against highly pathogenic simian/human immunodeficiency virus infection in macaques. (2012) (2)
- Synthesis of Sulfated Alkyl Malto‐ and Laminara‐oligosaccharides with Potent Inhibitory Effects on AIDS Virus Infection. (1994) (2)
- Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro. (2008) (2)
- CXCR4 Antagonists Identified as Anti-Cancer-Metastatic Agents (2004) (1)
- Evaluation of a synthetic C 34 trimer of HIV-1 gp 41 as AIDS vaccines (2012) (1)
- Identification of Binding Proteins of an Anti-HIV Peptide, T22 (1995) (1)
- Corrigendum: A Synthetic C34 Trimer of HIV‐1 gp41 Shows Significant Increase in Inhibition Potency (2012) (1)
- The Relationship between Conformation and Biological Activity of 8-substituted Analogues of 2′,5′-Oligoadenylates (1994) (1)
- [Acquired immunodeficiency syndrome (AIDS) and human immunodeficiency virus (HIV), and chemotherapeutic approaches to AIDS]. (1988) (1)
- A Novel Assay System for Anti‐Human Immunodeficiency Virus Type 1 (HIV‐1) Activity Using a Subclone of a Monocytic Cell Line, U937 (1994) (1)
- Synthesis of Oligodeoxyribonucleotide Analogues by Use of Deoxyribonucleoside-3′-yl O-bis(1,1,1,3,3,3-Hexafluoro-2-Propyl) Phosphites as New Key Intermediates (1992) (1)
- An anti-HIV peptide T22 is confirmed to be a selective CXCR4/fusin inhibitor by comparative inhibition study of a chemokine SDF-1, synthesized by regioselective disulfide bond formation (1999) (1)
- Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating (1992) (1)
- Characterization and biological activity of 8-substituted analogues of 2',5'-oligoadenylates. (1993) (1)
- Low‐Molecular‐Weight Anti‐HIV‐1 Peptides from the Amino‐Terminal Sequence of Rantes: Possible Lead Compounds for Coreceptor‐Directed Anti‐HIV‐1 Agents. (1999) (1)
- [Progress of basic research on HIV/AIDS: HIV entry mechanism: comparison with influenza virus]. (2010) (1)
- Interaction of TIBO and TIBO-like compounds with HIV-1 RT (1991) (1)
- Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase. (1995) (1)
- New substances against human immunodeficiency virus: sulfated 5'-nucleotidase inhibitory polyphenols. (1992) (1)
- [Replication inhibitors targeting early events in the HIV-1 life cycle]. (2002) (1)
- Synthesis and Biological Evaluation of Peptidomimetic Analogs of the CXCR4 Antagonist FC131 (2006) (0)
- HIV-cell Fusion Inhibitors Targeted to the HIV Second Receptor : T22 and Its Downsized Analogs with High Activity (1998) (0)
- AIDS: How Do We Overcome This Social or Biodisaster? (2007) (0)
- Inhibition of Simian immunodeficiency virus (SIV) from African green monkeys by TIBO and HEPT derivatives (1992) (0)
- Antisense Oligonucleotide as Anti-HIV Agents. (1993) (0)
- Solution RNA structure of loop region of the HIV-1 dimerization initiation site in the kissing-loop dimer (2005) (0)
- Structures and activities of tannins in crude drugs. IV: Effects on phagocytes and viruses (1992) (0)
- virus-cell fusion. Lys-7)polyphemusin II): a possible inhibitor of a novel synthetic peptide, T22 ((Tyr-5,12, Anti-human immunodeficiency virus activity of (2014) (0)
- Down regulation of human immunodeficiency virus type-1 (HIV-1) expression by Vif antisense RNA expression vectors in transfected cells. (2002) (0)
- Sulfated oligosaccharide aromatic glycoside (1992) (0)
- Highly Potent andSelective Inhibition ofHumanImmunodeficiency Virus bytheBicyclam Derivative JM3100 (1994) (0)
- Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity. (1991) (0)
- Design, Synthesis and Activity of Shortened Analogs of an Anti-HIV Peptide, T22 (1995) (0)
- Solution RNA structure of loop region of the HIV-1 dimerization initiation site in the extended-duplex dimer (2005) (0)
- Structure-Activity Relationship Study of CXCR4 Antagonists on the Cyclic Pentapeptide Scaffold : Identification of New Pharmacophore Moieties (2009) (0)
- [Development of anti-HIV drugs targeted to the coreceptors]. (1998) (0)
- Anti-HIV activities and mechanisms of antisense oligonucleotides (1996) (0)
- Anti-HIV activity and conformational analysis of a novel synthetic peptide, T22 ([Tyr5,12, Lys7]-Polyphemusin II) (1994) (0)
- Synthesis of Sulfonated Amino‐Polysaccharides Having Anti‐HIV and Blood Anticoagulant Activities. (1999) (0)
- Highly selective and potent inhibition of human immunodeficiency virus (HIV) by the novel bicyclam derivative JM3100 (1993) (0)
- INHIBITION BY ANTIBIOTICS OF AMV REVERSE TRANSCRIPTASE AND IN VITRO REPLICATION OF AIDS-VIRUS (1987) (0)
- Nucleosides and Nucleotides. Part 85. Synthesis and Anti-HIV Activity of 3′-Cyano-2′,3′-dideoxythymidine and 3′-Cyano-2′,3′-didehydro-2′,3′-dideoxythymidine. (1989) (0)
- Identification of a Polyphemusin Analog(T22)-Zn(II) Complex by Mass Spectrometric Analysis and Its Anti-HIV Activity (1996) (0)
- Inhibitory activity of lipophilic 2′,3′-dideoxynucleoside derivatives against HIV (1991) (0)
- Efficient analogs of an anti-HIV peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), having low cytotoxicity (1999) (0)
- Quantitative evaluation of inactivation of HIV by several chemical disinfectants (1989) (0)
- Use of glycans as antiviral compounds. (1988) (0)
- Synthesis of a CC Chemokine, vMIP-II, Encoded by Kaposi's Sarcoma-Associated Herpesvirus and Its Biological Activity (1998) (0)
- 2P055 Rational design of peptides that inhibit HIV-1 integrase activity by docking simulation(Proteins-structure and structure-function relationship,Poster Presentations) (2007) (0)
- Solution RNA structure model of the HIV-1 dimerization initiation site in the extended-duplex dimer (2005) (0)
- THE JOURNAL OF ANTIBIOTICS INHIBITION BY DOXORUBICIN OF HUMANIMMUNO-DEFICIENCY VIRUS (HIV) INFECTION AND REPLICATION IN VITRO (2006) (0)
- Synthesis of Sulfated Polysaccharides with a Long Alkyl Chain. (1991) (0)
- An antiviral agent for the inhibition of the growth of the AIDS syndrome virus. (1987) (0)
- Development of Fluorescent Labeled CXCR4 Specific Ligand for Imaging and Fluorescence-Based Screening (2009) (0)
- Identification of Sequential Motifs Relevant to Inhibitory Activity against HIV Integrase (2008) (0)
- Solution RNA structure model of the HIV-1 dimerization initiation site in the kissing-loop dimer (2005) (0)
- Designed Antigens Based on the Dynamic Structural Changes of gp41 for Development of Effective HIV -1 Vaccines (2012) (0)
- STRUCTURE-ACTIVITY RELATIONSHIPS OF TACHYPLESIN ANALOGS AS ANTI-HIV AGENT (1992) (0)
- [How to evaluate anti-HIV activity]. (1993) (0)
- Synthesis of RANTES-related peptides and their effect on human immunodeficiency virus-1 infection (1999) (0)
- Stereo-controlled Synthesis of [L-Arg, L/D-3-(2-Naphthyl)alanine]-type (E)-Alkene Dipeptide Isosteres and its Application to the Preparation and Biological Evaluation of Peptidomimetic Analogs of the CXCR4 Antagonist FC131 (2006) (0)
- Synthesis and Evaluation of CXCR4-derived Peptides Targeting the Development of AIDS Vaccines (2011) (0)
- Development of the Chemokine Receptor CXCR4 Antagonists as Multi-Pharmaceutical Agents Involving a New Class of Low Molecular Weight Antagonists (2007) (0)
- Ny Science daerav framstaelld the polypeptide of HIV Medicine. (1992) (0)
- Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract. (2000) (0)
- New polypeptides and anti-HIV drugs made thereof (1991) (0)
- Development of Inhibitory Peptides against HIV-1 Integrase (2009) (0)
- HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), and its related compounds (1999) (0)
- Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study (2012) (0)
- New Leads of Low Molecular Weight CXCR4 Antagonists Based on Enhancement of the T140-based Pharmacophores (2004) (0)
- Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses (1992) (0)
- Novel Second Generation Anti-HIV shRNA Expressing vif and Decoy TAR Arrest the Virus-breakthrough Phenomenon Associated With siRNA-escape Variants (2005) (0)
- Solution RNA structure of stem-bulge-stem region of the HIV-1 dimerization initiation site (2005) (0)
- Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides. (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Naoki Yamamoto?
Naoki Yamamoto is affiliated with the following schools:
